Libertarian Land: Rethinking the FDA
If the FDA approves a bad drug, the adverse outcomes make headlines. If the FDA delays a good drug, the cost is less obvious because most of those affected are not aware their illness could have been treated more effectively.
Over the past two and a half years, critics old and new have blasted the Food and Drug Administration for excessive caution and bureaucratic delay in response to the Covid crisis.
Please check your email.
A verification code has been sent to
Didn't get a code? Click to resend.
Have an account? Log In
To continue reading, please select:
Limited Access
Enter your email to read for FREE
Get 1 FREE article
Continue with
or
Unlimited Access
Join the Sun for a PENNY A DAY
$0.01/day for 60 days
Cancel anytime
100% ad free experience
Unlimited article and commenting access
Full annual dues ($120) billed after 60 days
